FindTrial
Sign In

(1stweek) -15&amp

2 trials

Sponsors

Sanofi Synthelabo A Sir Mathuradas Vasanji Road AndheriE Mumbai India, Sanofi Synthelabo A Sir Mathuradas Vasanji Road AndheriE Mumbai

Conditions

Health Condition 1: null- In Patients With Type 2 Diabetes insufficiently controlled with basal insulin for the assessment of the efficacy and Safety Evaluation Health Condition 2: E119- Type 2 diabetes mellitus without complicationsHealth Condition 1: null- Type 2 Diabetes for Glycemic Control and Safety Evaluation Health Condition 2: E119- Type 2 diabetes mellitus without complications

Phase 3

A clinical study to evaluate the effects of GLP-1 agonist AVE0010 in paTients with type 2 diabetes mellitus for Glycemic cOntrol and sAfety evaLuation, on top of Sulfonylurea
Active, not recruitingCTRI/2008/091/000176
Sanofi Synthelabo A Sir Mathuradas Vasanji Road AndheriE Mumbai IndiaHealth Condition 1: null- Type 2 Diabetes for Glycemic Control and Safety Evaluation Health Condition 2: E119- Type 2 diabetes mellitus without complications
Target: 855Updated: 2021-11-24
GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
Active, not recruitingCTRI/2008/091/000180
Sanofi Synthelabo A Sir Mathuradas Vasanji Road AndheriE MumbaiHealth Condition 1: null- In Patients With Type 2 Diabetes insufficiently controlled with basal insulin for the assessment of the efficacy and Safety Evaluation Health Condition 2: E119- Type 2 diabetes mellitus without complications
Target: 496Updated: 2021-11-24